# One-month Latent Tuberculosis Treatment for Renal Transplant Candidates

> **NCT05411744** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 25 (estimated)

## Conditions studied

- Latent Tuberculosis
- End Stage Renal Disease
- Renal Transplant Candidate for Right Kidney
- Renal Transplant Candidate for Left Kidney

## Interventions

- **DRUG:** 1 month Rifapentine, Isoniazid and Vitamin B6

## Key facts

- **NCT ID:** NCT05411744
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2026-01-16
- **Final completion:** 2029-06-30
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411744, "One-month Latent Tuberculosis Treatment for Renal Transplant Candidates". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05411744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*